SOLTI-1507: A phase Ib study of ipatasertib and anti-HER2 therapy in HER2-positive advanced breast cancer with PIK3CA mutation (IPATHER)

Simple item page
dc.conference.dateSEP 19-OCT 18, 2020
dc.conference.titleESMO Virtual Congress
dc.contributor.authorOliveira, M.
dc.contributor.authorVillagrasa, P.
dc.contributor.authorCiruelos, E. M.
dc.contributor.authorGavila, J.
dc.contributor.authorCortegoso, A.
dc.contributor.authorHenao, F.
dc.contributor.authorVega, E.
dc.contributor.authorSalvador, J.
dc.contributor.authorQuiroga, V.
dc.contributor.authorEstevez, L. G.
dc.contributor.authorMorales, S.
dc.contributor.authorTolosa, P.
dc.contributor.authorSalvador, F.
dc.contributor.authorGonzalez, X.
dc.contributor.authorSaura, C.
dc.contributor.authoraffiliation[Oliveira, M.] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Saura, C.] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Villagrasa, P.] SOLTI Breast Canc Res Grp, Clin Res, Barcelona, Spain
dc.contributor.authoraffiliation[Salvador, F.] SOLTI Breast Canc Res Grp, Clin Res, Barcelona, Spain
dc.contributor.authoraffiliation[Ciruelos, E. M.] Univ Hosp 12 Octubre, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Tolosa, P.] Univ Hosp 12 Octubre, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Gavila, J.] Inst Valenciano Oncol, Dept Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Cortegoso, A.] Complejo Hosp Univ de Santiago, Med Oncol Serv, Santiago De Compostela, Spain
dc.contributor.authoraffiliation[Henao, F.] Hosp Virgen de Macarena, Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Vega, E.] Ctr Integral Oncol Clara Campal, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Salvador, J.] Hosp Virgen del Rocio, Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Quiroga, V.] Catalan Inst Oncol, Med Oncol, Badalona Appl Res Grp Oncol B ARGO Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Estevez, L. G.] Hosp MD Anderson Canc Ctr Madrid, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Morales, S.] Hosp Arnau Vilanova, Med Oncol, Lleida, Spain
dc.contributor.authoraffiliation[Gonzalez, X.] Inst Oncol Dr Rosell, Med Oncol, Barcelona, Spain
dc.contributor.funderHoffmann-La Roche
dc.date.accessioned2025-01-07T16:00:46Z
dc.date.available2025-01-07T16:00:46Z
dc.date.issued2020-09-01
dc.identifier.doi10.1016/j.annonc.2020.08.453
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420404491/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27556
dc.identifier.wosID573469100351
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS389-S389
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleSOLTI-1507: A phase Ib study of ipatasertib and anti-HER2 therapy in HER2-positive advanced breast cancer with PIK3CA mutation (IPATHER)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen del Rocío
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía